Back to Search Start Over

American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations.

Authors :
Forbes N
Elhanafi SE
Al-Haddad MA
Thosani NC
Draganov PV
Othman MO
Ceppa EP
Kaul V
Feely MM
Sahin I
Buxbaum JL
Calderwood AH
Chalhoub JM
Coelho-Prabhu N
Desai M
Fujii-Lau LL
Kohli DR
Kwon RS
Machicado JD
Marya NB
Pawa S
Ruan W
Sheth SG
Storm AC
Thiruvengadam NR
Qumseya BJ
Source :
Gastrointestinal endoscopy [Gastrointest Endosc] 2023 Sep; Vol. 98 (3), pp. 271-284. Date of Electronic Publication: 2023 Jul 25.
Publication Year :
2023

Abstract

This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based summary and recommendations regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. It is accompanied by the document subtitled "Methodology and Review of Evidence," which provides a detailed account of the methodology used for the evidence review. This guideline was developed using the Grading of Recommendations, Assessment, Development and Evaluation framework and specifically addresses the role of ESD versus EMR and/or surgery, where applicable, for the management of early esophageal squamous cell carcinoma (ESCC), esophageal adenocarcinoma (EAC), and gastric adenocarcinoma (GAC) and their corresponding precursor lesions. For ESCC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >15 mm, whereas in patients with similar lesions ≤15 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for such patients with ESCC, whenever possible. For EAC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >20 mm, whereas in patients with similar lesions measuring ≤20 mm, the ASGE suggests either ESD or EMR. For GAC, the ASGE suggests ESD over EMR for patients with early-stage, well- or moderately differentiated, nonulcerated intestinal type cancer measuring 20 to 30 mm, whereas for patients with similar lesions <20 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for patients with such lesions measuring ≤30 mm, whereas for lesions that are poorly differentiated, regardless of size, we suggest surgical evaluation over endoscopic approaches.<br /> (Copyright © 2023 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-6779
Volume :
98
Issue :
3
Database :
MEDLINE
Journal :
Gastrointestinal endoscopy
Publication Type :
Academic Journal
Accession number :
37498266
Full Text :
https://doi.org/10.1016/j.gie.2023.03.015